Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -31.02%1.64B | 41.93%2.37B | -24.45%1.67B | -5.67%2.21B | 19.03%2.35B | 252.59%1.97B | 219.43%559M | -83.94%175M | 1,658.06%1.09B | -90.98%62M |
Net profit before non-cash adjustment | 16.84%1.91B | -28.13%1.63B | -5.21%2.27B | 35.35%2.4B | 20.64%1.77B | 26.01%1.47B | 3.83%1.17B | 2.65%1.12B | 340.73%1.09B | 19.81%248M |
Total adjustment of non-cash items | -11.71%407M | 61.19%461M | 959.26%286M | -95.48%27M | 708.11%598M | -62.24%74M | -40.43%196M | 46.22%329M | 55.17%225M | -42.23%145M |
-Depreciation and amortization | 2.12%193M | -5.03%189M | 8.15%199M | -2.65%184M | -1.05%189M | 18.63%191M | 2.55%161M | 3.97%157M | 11.03%151M | -9.33%136M |
-Reversal of impairment losses recognized in profit and loss | 84.87%220M | 22.68%119M | --97M | ---- | 47.06%225M | --153M | ---- | --138M | ---- | -41.67%14M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 368.57%94M | -333.33%-35M |
-Disposal profit | --14M | --0 | ---- | ---- | ---- | ---325M | ---- | ---4M | ---- | ---- |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -342.86%-62M | ---14M |
-Other non-cash items | -113.07%-20M | 1,630.00%153M | 93.63%-10M | -185.33%-157M | 234.55%184M | 57.14%55M | -7.89%35M | -9.52%38M | -4.55%42M | -10.20%44M |
Changes in working capital | -344.24%-679M | 131.41%278M | -323.44%-885M | -770.83%-209M | -105.63%-24M | 152.92%426M | 36.91%-805M | -459.65%-1.28B | 31.12%-228M | -244.54%-331M |
-Change in receivables | -1,165.31%-1.24B | 94.08%-98M | -270.47%-1.66B | ---447M | --0 | 72.20%-350M | -23.55%-1.26B | -53.00%-1.02B | 31.20%-666M | -100.00%-968M |
-Change in inventory | 230.12%337M | -398.08%-259M | -140.94%-52M | 1,714.29%127M | -94.93%7M | -48.89%138M | -4.59%270M | 1,668.75%283M | -97.32%16M | 220.43%596M |
-Change in payables | -111.96%-44M | 484.13%368M | -33.68%63M | 195.00%95M | -116.45%-100M | 188.15%608M | 143.87%211M | -215.90%-481M | 312.82%415M | -142.12%-195M |
-Provision for loans, leases and other losses | 500.00%12M | -77.78%2M | 126.47%9M | -278.95%-34M | 120.21%19M | -840.00%-94M | 37.50%-10M | ---16M | ---- | ---- |
-Changes in other current assets | -3.40%256M | -64.71%265M | 1,402.00%751M | 0.00%50M | -59.68%50M | 829.41%124M | 60.47%-17M | -714.29%-43M | -97.03%7M | 268.75%236M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 33.33%-4M | 40.00%-6M | 23.08%-10M | 31.58%-13M | 38.71%-19M | 11.43%-31M | 5.41%-35M | 19.57%-37M | 8.00%-46M | 9.09%-50M |
Interest received (cash flow from operating activities) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20.00%4M | -28.57%5M | -12.50%7M |
Tax refund paid | 61.61%-205M | 19.70%-534M | 21.95%-665M | -123.62%-852M | 6.62%-381M | 8.11%-408M | 19.57%-444M | -475.00%-552M | 56.56%-96M | -1,600.00%-221M |
Other operating cash inflow (outflow) | 50.00%-1M | -100.00%-2M | 0.00%-1M | -200.00%-1M | 1M | 0 | 0 | 238.18%152M | -177.46%-110M | 224.56%142M |
Operating cash flow | -22.06%1.43B | 83.84%1.83B | -26.06%996M | -30.82%1.35B | 27.09%1.95B | 1,815.00%1.53B | 131.01%80M | -130.60%-258M | 1,505.00%843M | -111.70%-60M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 0.69%-289M | -22.27%-291M | 6.67%-238M | -34.21%-255M | -279.25%-190M | 116.08%106M | -85.63%-659M | -61.36%-355M | 13.73%-220M | -65.58%-255M |
Net intangibles purchase and sale | --0 | ---8M | --0 | ---- | ---- | 98.65%-1M | ---74M | --0 | ---- | ---- |
Net investment product transactions | 92.17%-31M | -2.06%-396M | -0.52%-388M | -38,700.00%-386M | --1M | ---- | ---145M | ---- | ---- | ---- |
Net changes in other investments | 126.67%4M | -175.00%-15M | 322.22%20M | 91.59%-9M | -141.80%-107M | 383.02%256M | -56.20%53M | 152.08%121M | -42.17%48M | -79.85%83M |
Investing cash flow | 55.49%-316M | -17.16%-710M | 6.77%-606M | -119.59%-650M | -181.99%-296M | 143.76%361M | -252.56%-825M | -36.05%-234M | 0.00%-172M | -155.84%-172M |
Financing cash flow | ||||||||||
Net issuance payments of debt | 23.89%-411M | 9.40%-540M | 1.16%-596M | 59.58%-603M | -24.85%-1.49B | -215.01%-1.2B | 1,891.38%1.04B | 65.06%-58M | -348.65%-166M | 80.93%-37M |
Net common stock issuance | --0 | --0 | ---- | --571M | ---- | ---- | ---- | ---- | ---- | ---- |
Increase or decrease of lease financing | --0 | --0 | ---3M | --0 | --0 | --0 | --0 | --0 | --0 | 91.07%-5M |
Cash dividends paid | 5.68%-216M | -6.02%-229M | -19.34%-216M | -29.29%-181M | -21.74%-140M | -0.88%-115M | -12.87%-114M | 0.00%-101M | 0.00%-101M | -34.67%-101M |
Net other fund-raising expenses | 50.00%-1M | -100.00%-2M | 50.00%-1M | ---2M | ---- | 50.00%-1M | -100.00%-2M | 0.00%-1M | 0.00%-1M | 0.00%-1M |
Financing cash flow | 18.55%-628M | 5.51%-771M | -279.53%-816M | 86.83%-215M | -24.49%-1.63B | -242.04%-1.31B | 676.88%923M | 40.30%-160M | -86.11%-268M | 53.25%-144M |
Net cash flow | ||||||||||
Beginning cash position | 32.83%1.42B | -28.60%1.07B | 47.68%1.49B | 1.81%1.01B | 142.20%993M | 76.72%410M | -73.81%232M | 83.06%886M | -43.79%484M | 147.41%861M |
Current changes in cash | 38.00%483M | 182.16%350M | -188.38%-426M | 2,436.84%482M | -96.74%19M | 226.97%582M | 127.30%178M | -261.79%-652M | 207.18%403M | -173.29%-376M |
Effect of exchange rate changes | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cash adjustments other than cash changes | ---- | ---- | ---1M | ---- | -200.00%-1M | --1M | ---- | -100.00%-2M | 0.00%-1M | ---1M |
End cash Position | 34.11%1.9B | 32.83%1.42B | -28.60%1.07B | 47.68%1.49B | 1.81%1.01B | 142.20%993M | 76.72%410M | -73.81%232M | 83.06%886M | -43.79%484M |
Free cash flow | -25.72%1.14B | 102.11%1.53B | -30.59%758M | -37.85%1.09B | 133.02%1.76B | 215.47%754M | -6.53%-653M | -198.39%-613M | 297.78%623M | -187.74%-315M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |